Literature DB >> 10624495

A retrospective study of epinephrine administration for anaphylaxis: how many doses are needed?

P Korenblat1, M J Lundie, R E Dankner, J H Day.   

Abstract

The precise amount of epinephrine needed to reverse severe symptomatology due to an anaphylactic reaction is unknown. We tried to determine how frequently more than one injection of epinephrine is required to treat an anaphylactic reaction. A retrospective review of patient charts with anaphylactic reactions requiring epinephrine, in response to inhalant allergen and hymenoptera venom immunotherapy as well as live hymenoptera stings, examined type of reaction; number, doses, and timing of epinephrine administered; and ancillary treatment. A total of 105 anaphylactic reaction events of varying severity (Ring's classification) were recorded (54--Grade I, 29--Grade II, 18--Grade III, 0--Grade IV, 4--unknown). The median epinephrine dose administered was 0.3 cc (range 0.1 to 0.8 cc, 1:1000). The timing of the first epinephrine injection was < or = 5 minutes in 27, 6-10 minutes in 13, 11-30 minutes in 16, < or = 30 minutes in 32, 31-60 minutes in 12, and > 60 minutes in five epinephrine treated patients. Overall, 38 patients (35.5%; CI95, 26.4-44.6%) required > 1 epinephrine injection. Of these, 11 experienced Grade I (11/54-20.3%; CI95, 9.6-31.0%), 12--Grade II (12/29-41.5%, CI95, 23.5-59.3%), and 13--Grade III (13/18-72.2%, CI95, 51.5-92.9%); reactivity was unknown in 2 patients. Forty-four patients also received an antihistamine, 10 received corticosteroids, and 30 received both medications and/or other ancillary therapy. A significant number of patients (> 35%) with anaphylactic reactions received greater than one epinephrine dose to manage events for the three classes of severity. Patients at risk for anaphylaxis and their caregivers need to recognize that more than one dose of epinephrine may be required for treatment of anaphylaxis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10624495     DOI: 10.2500/108854199778251834

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  13 in total

1.  Treatment of anaphylaxis: EpiPen, Twinject, or another autoinjector?

Authors:  Alexandre Ackaoui
Journal:  Can Fam Physician       Date:  2011-03       Impact factor: 3.275

2.  Use of Epinephrine in Patients with Drug-Induced Anaphylaxis: An Analysis of the Beijing Pharmacovigilance Database.

Authors:  Tiansheng Wang; Xiang Ma; Yan Xing; Shusen Sun; Hua Zhang; Til Stürmer; Bin Wang; Xiaotong Li; Huilin Tang; Ligong Jiao; Suodi Zhai
Journal:  Int Arch Allergy Immunol       Date:  2017-05-16       Impact factor: 2.749

3.  Guidelines for Bystander First Aid 2016.

Authors:  Jen Heng Pek
Journal:  Singapore Med J       Date:  2017-07       Impact factor: 1.858

Review 4.  Glucocorticoids for the treatment of anaphylaxis.

Authors:  Karen Jui Lin Choo; F Estelle R Simons; Aziz Sheikh
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18

5.  Epinephrine treatment is infrequent and biphasic reactions are rare in food-induced reactions during oral food challenges in children.

Authors:  Kirsi M Järvinen; Sujitha Amalanayagam; Wayne G Shreffler; Sally Noone; Scott H Sicherer; Hugh A Sampson; Anna Nowak-Wegrzyn
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

6.  Factors associated with repeated use of epinephrine for the treatment of anaphylaxis.

Authors:  Veena Manivannan; Ronna L Campbell; M Fernanda Bellolio; Latha G Stead; James T C Li; Wyatt W Decker
Journal:  Ann Allergy Asthma Immunol       Date:  2009-11       Impact factor: 6.347

Review 7.  The post-anaphylaxis dilemma: how long is long enough to observe a patient after resolution of symptoms?

Authors:  Stephen F Kemp
Journal:  Curr Allergy Asthma Rep       Date:  2008-03       Impact factor: 4.806

8.  Characteristics of food-allergic patients placing them at risk for a fatal anaphylactic episode.

Authors:  Anne Muñoz-Furlong; Christopher C Weiss
Journal:  Curr Allergy Asthma Rep       Date:  2009-01       Impact factor: 4.806

Review 9.  Adrenaline auto-injectors for the treatment of anaphylaxis with and without cardiovascular collapse in the community.

Authors:  Aziz Sheikh; F Estelle R Simons; Victoria Barbour; Allison Worth
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

Review 10.  Recent Advances in 3D Printing for Parenteral Applications.

Authors:  Ryan Ivone; Yan Yang; Jie Shen
Journal:  AAPS J       Date:  2021-06-18       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.